KeyNeurotek Pharma Raises Series C
KeyNeurotek Pharmaceuticals AG, a German drug developer focused on autoimmune diseases and degenerative CNS disorders, has raised €8.2 million in Series C funding. Return backers include DVC Deutsche Venture Capital, IBG Beteiligungsgesellschaft and KfW.
8 April 2009•3 mins read
